🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the safety of 52 weeks onc...
Status
Completed
Location
1237.22.81015 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01536262
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.9.00152 Boehringer Ingelheim Investigational Site
Start Date
2008-07
Trial ID
NCT00720499
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of 12 week...
Status
Completed
Location
1237.26.10620 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT02006732
Treatments Being Tested
The aim of this trial is to evaluate the safety and efficacy of 2.5 and 5 µ...
Status
Completed
Location
205.464.81020 Boehringer Ingelheim Investigational Site
Start Date
2011-04
Trial ID
NCT01340209
Treatments Being Tested
The objective of the trial is to compare the lung function profile of once ...
Status
Completed
Location
1237.11.32002 Boehringer Ingelheim Investigational Site
Start Date
2013-10
Trial ID
NCT01969721
The overall objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
1237.5.01038 Boehringer Ingelheim Investigational Site
Start Date
2011-09
Trial ID
NCT01431274
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.4.0118 Boehringer Ingelheim Investigational Site
Start Date
2008-06
Trial ID
NCT00696020
Treatments Being Tested
The study is intended to characterize the lung function profile of BI1744 i...
Status
Completed
Location
1222.39.32003 Boehringer Ingelheim Investigational Site
Start Date
2010-01
Trial ID
NCT01040689
The primary objective of this trial is to investigate the effect of 6 weeks...
Status
Completed
Location
1237.14.01404 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01533935
Treatments Being Tested
The primary objective of this study is to assess pharmacokinetics of tiotro...
Status
Completed
Location
1237.24.24001 Boehringer Ingelheim Investigational Site
Start Date
2012-10
Trial ID
NCT01703845
Treatments Being Tested